|
Volume 11 Issue 2
|
|
Comment |
|
|
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer
Pepper Schedin, Virginia Borges Breast Cancer Research 2009, 11:102 (26 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
The breast cancer somatic 'muta-ome': tackling the complexity
Andrew E Teschendorff, Carlos Caldas Breast Cancer Research 2009, 11:301 (30 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Number crunching in the cancer stem cell market
Malcolm R Alison, Shahriar Islam, Susan ML Lim Breast Cancer Research 2009, 11:302 (24 April 2009)
Abstract | Full text | PDF | PubMed
|
|
Review |
|
|
Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents
Michael Untch, Gunter von Minckwitz Breast Cancer Research 2009, 11:203 (17 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer
Sara López-Tarruella, Miguel Martín Breast Cancer Research 2009, 11:204 (19 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer
Catherine Oakman, Silvia Bessi, Elena Zafarana, Francesca Galardi, Laura Biganzoli, Angelo Di Leo Breast Cancer Research 2009, 11:205 (3 April 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
Research |
|
|
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody, Uwe Holtrich, Laos Pusztai, Cornelia Liedtke, Regine Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, Andre Ahr, Dirk Metzler, Knut Engels, Thomas Karn, Manfred Kaufmann Breast Cancer Research 2009, 11:R15 (9 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
The T-cell metagene LCK identifies ER negative breast cancers, commonly associated with poor disease free survival, and may also identify differences in prognosis within this tumor subtype.
|
|
|
Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity
Antonis Kourtidis, Rekha Srinivasaiah, Richard D Carkner, M Julia Brosnan, Douglas S Conklin Breast Cancer Research 2009, 11:R16 (19 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
TLE3 as a candidate biomarker of response to taxane therapy
Swati A Kulkarni, David G Hicks, Nancy L Watroba, Christine Murekeyisoni, Helena Hwang, Thaer Khoury, Rodney A Beck, Brian Z Ring, Noel C Estopinal, Marshall T Schreeder, Robert S Seitz, Douglas T Ross Breast Cancer Research 2009, 11:R17 (23 March 2009)
Abstract | Full text | PDF | PubMed
|
|
|
Triple-negative breast cancers are increased in black women regardless of age or body mass index
Lesley A Stead, Timothy L Lash, Jerome E Sobieraj, Dorcas D Chi, Jennifer L Westrup, Marjory Charlot, Rita A Blanchard, John C Lee, Thomas C King, Carol L Rosenberg Breast Cancer Research 2009, 11:R18 (25 March 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Triple negative breast tumors are three times more common in black than non-black women, regardless of age and BMI, and may contribute to black women's poorer breast cancer prognosis.
|
|
|
Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype
Kevin Roarty, Sarah E Baxley, Michael R Crowley, Andra R Frost, Rosa Serra Breast Cancer Research 2009, 11:R19 (3 April 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Loss of TGF-ß or Wnt5a, proteins involved in Wnt/ß-catenin regulation, can redirect the phenotype of mammary tumours to resemble those induced by excessive Wnt/ß-catenin, suggesting a new tumour suppressive mechanism.
|
|
|
Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells
Kara L Britt, Howard Kendrick, Joseph L Regan, Gemma Molyneux, Fiona-Ann Magnay, Alan Ashworth, Matthew J Smalley Breast Cancer Research 2009, 11:R20 (23 April 2009)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
No significant differences exist in stem/progenitor cell numbers between mammary epithelium isolated from mature adult mice that had been through pregnancy at nine weeks old, and age-matched virgin mice.
|
|
|
Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis
Johanna R Reed, Ronald P Leon, Majken K Hall, Kathryn L Schwertfeger Breast Cancer Research 2009, 11:R21 (24 April 2009)
Abstract | Full text | PDF | PubMed
|
|
|
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer
Byoung Kim, Jong Lee, Pil Park, Yong Shin, Won Lee, Kyung Lee, Sena Ye, Heesun Hyun, Kyung Kang, Donghwa Yeo, Youngdai Kim, Sung Ohn, Dong Noh, Chul Kim Breast Cancer Research 2009, 11:R22 (28 April 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer
Jocelyne Jacquemier, Emmanuelle Charafe-Jauffret, Florence Monville, Benjamin Esterni, Jean Extra, Gilles Houvenaeghel, Luc Xerri, François Bertucci, Daniel Birnbaum Breast Cancer Research 2009, 11:R23 (30 April 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
Rachael A Hancox, Michael D Allen, Deborah L Holliday, Dylan R Edwards, Caroline J Pennington, David S Guttery, Jacqueline A Shaw, Rosemary A Walker, J Howard Pringle, J Louise Jones Breast Cancer Research 2009, 11:R24 (30 April 2009)
Abstract | Full text | PDF | PubMed
|
|
Correspondence |
|
|
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
Alma Carracedo, Kristof Egervari, Marta Salido, Federico Rojo, Josep M Corominas, Montserrat Arumi, Cristina Corzo, Ignacio Tusquets, Blanca Espinet, Ana Rovira, Joan Albanell, Zoltan Szollosi, Sergi Serrano, Francesc Solé Breast Cancer Research 2009, 11:402 (21 April 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|